N-Carbethoxy-4-piperidone
CAS No. 29976-53-2
N-Carbethoxy-4-piperidone( —— )
Catalog No. M13925 CAS No. 29976-53-2
Aminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameN-Carbethoxy-4-piperidone
-
NoteResearch use only, not for human use.
-
Brief DescriptionAminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals.
-
DescriptionAminopyrimidine derivatives, processes for their preparation, compositions containing them and their use as pharmaceuticals.
-
In VitroN-Carbethoxy-4-piperidone (piperidinone 4) shows toxicity to C. dubia, B. calyciflorus and P. subcapitata.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number29976-53-2
-
Formula Weight171.19
-
Molecular FormulaC8H13NO3
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESCCOC(=O)N1CCC(=O)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Eric Gundersen et al.Bioorganic & Medicinal Chemistry Letters, 15(7), 1891-1894 (2005)
molnova catalog
related products
-
Linderene acetate
Linderene acetate is a competitive inhibitor against Prolyl endopeptidase.
-
(R)-3-Hydroxybutanoi...
3-hydroxybutyric acid is involved in the synthesis and degradation of ketone bodies. Like the other ketone bodies (acetoacetate and acetone) levels of beta-hydroxybutyrate are raised in the blood and urine in ketosis. Beta-hydroxybutyrate is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis.
-
GSK199
GSK199 is a selective PAD4 inhibitor(IC50 of 200 nM in the absence of calcium).
Cart
sales@molnova.com